1999
DOI: 10.1006/mcbr.1999.0123
|View full text |Cite
|
Sign up to set email alerts
|

Expression of a Y559F Mutant CSF-1 Receptor in M1 Myeloid Cells: A Role for Src Kinases in CSF-1 Receptor-Mediated Differentiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
86
1

Year Published

2005
2005
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(90 citation statements)
references
References 22 publications
3
86
1
Order By: Relevance
“…4B) confirm the central role of the Erk1/2 pathway in CSF-1-induced differentiation (Wilson et al 2005). In myeloblasts, a CSF-1R pTyr-559/SFK pathway initiates the activation of STAT3 (Marks et al 1999) and Erk1/ 2 and the inactivation of PP2A, which plays a significant role in enhancing Erk1/2-mediated macrophage differentiation . In multipotent cells, via a SFK-independent pathway, Gab2 becomes tyrosine phosphorylated, associating with signaling molecules, including Grb2, Shp2, and p85, to activate Erk1/2 and differentiation (Liu et al 2001).…”
Section: Csf-1 Receptor Signaling In Myeloid Cellsmentioning
confidence: 53%
“…4B) confirm the central role of the Erk1/2 pathway in CSF-1-induced differentiation (Wilson et al 2005). In myeloblasts, a CSF-1R pTyr-559/SFK pathway initiates the activation of STAT3 (Marks et al 1999) and Erk1/ 2 and the inactivation of PP2A, which plays a significant role in enhancing Erk1/2-mediated macrophage differentiation . In multipotent cells, via a SFK-independent pathway, Gab2 becomes tyrosine phosphorylated, associating with signaling molecules, including Grb2, Shp2, and p85, to activate Erk1/2 and differentiation (Liu et al 2001).…”
Section: Csf-1 Receptor Signaling In Myeloid Cellsmentioning
confidence: 53%
“…Therefore, blocking SFK activity with PP2 or SU6656 totally abrogated M-CSF differentiation signal in FD-Fms cells, which represents a more dramatic response than that previously reported in M1-Fms cells. 22 These unequivocal data also support the idea that SFK inhibitors would specifically target the signaling pathways responsible for M-CSFinduced differentiation.…”
Section: Effects Of the Sfk Inhibitor Pp2 On Sfk And M-csfr Kinase Acmentioning
confidence: 53%
“…Studies with M1 and 32D murine myeloid cell lines demonstrated Src-family kinases (SFK) binding to activated M-CSFR 21 and partial impairment of M-CSF-induced differentiation by the src kinase inhibitor PP2. 22 In addition to activation of specific signaling pathways, another important aspect of M-CSF signaling specificity is the strength and duration of signaling. It has long been known that continuous M-CSF stimulation is required for progression throughout the G1 phase of cell cycle and induction of early response genes.…”
Section: Introductionmentioning
confidence: 99%
“…26 Meanwhile, it is known that the tyrosine located in the juxtamembrane domain of Fms (Y561 in human and Y559 in murine) serves as a binding site for Src kinases including Hck when the residue is autophosphorylated. [51][52][53][54] However, when coexpressed with Hck, Nef also down-regulated a Fms mutant in which the tyrosine residue was replaced with phenylalanine (data not shown). Thus, the active Hck at the Golgi may interact with Fms via unidentified site(s) or form complexes with Fms indirectly.…”
Section: Discussionmentioning
confidence: 91%
“…Our finding that the degree to which the active Hck accumulated at the Golgi correlated well with that of the down-regulation of Fms ( Figures 4B,5B) strongly suggested that Nef down-regulated Fms through both the activation of Hck and the accumulation of the active Hck at the Golgi. The idea may answer why Hck, the downstream effector molecule important for the Fms signaling pathways, 38,[50][51][52][53] is involved in the downregulation of Fms by Nef.…”
Section: Discussionmentioning
confidence: 99%